Ashling Holland

Ashling Holland

Company: PepGen

Job title: Director of Preclinical Research & Development


Enhanced Delivery Oligonucleotide (EDO) – A Novel Delivery Platform for Superior Oligonucleotide Delivery 1:00 pm

EDOs are designed to enhance delivery of oligonucleotide therapeutics to muscle and other target tissues EDOs show higher uptake to muscle nuclei and corresponds with increased pharmacological activity in multiple preclinical models EDO platform has enabled initiation of 2 clinical programs, including a Phase 2 (CONNECT1-EDO51) study to investigate the effects of PGN-EDO51 in people…Read more

day: Pre-Conference Focus Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.